董事介绍
注：董事持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Peter Bloch | 男 | Independent Director | 65 | 未披露 | 1.82 | 2025-08-04 |
| Iris Bincovich | 女 | Chief Executive Officer and Director and Interim Chairwoman | 56 | 92.62万美元 | 20.70 | 2025-08-04 |
| Roni Kamhi | 男 | Chief Executive Officer of B.I. Sky and Chief Operating Officer and Director | 50 | 57.35万美元 | 8.21 | 2025-08-04 |
| Eyal Flom | 男 | Director and General Counsel | 59 | 未披露 | 10.36 | 2025-08-04 |
| Ralph C.L Bossino | 男 | Independent Director | 37 | 未披露 | 2.47 | 2025-08-04 |
| Joshua A. Lintern | 男 | Independent Director | 37 | 未披露 | 1.70 | 2025-08-04 |
高管介绍
注：高管持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Iris Bincovich | 女 | Chief Executive Officer and Director and Interim Chairwoman | 56 | 92.62万美元 | 20.70 | 2025-08-04 |
| Nelson Halpern | 男 | Chief Financial Officer | 67 | 8.30万美元 | 1.75 | 2025-08-04 |
| Roni Kamhi | 男 | Chief Executive Officer of B.I. Sky and Chief Operating Officer and Director | 50 | 57.35万美元 | 8.21 | 2025-08-04 |
| Eyal Kalo | 男 | Vice President of Research and Development | 48 | 未披露 | 1.20 | 2025-08-04 |
| Eyal Flom | 男 | Director and General Counsel | 59 | 未披露 | 10.36 | 2025-08-04 |
董事简历
中英对照 | 中文 | 英文- Peter Bloch
-
Peter Bloch自2013年4月起担任公司首席执行官，自2014年2月起担任董事会主席。从2012年4月到2013年4月，Bloch先生担任我们的首席财务官。Bloch先生是CA的注册会计师，有着建立公共和私人技术公司的记录，主要是在生命科学行业。Bloch从2008年1月到2009年2月担任Just Energy（一家公共电力和天然气公司）首席财务官。自2011年12月起，Bloch先生还担任Enerspar Corp.的董事。他过去25年的执行管理经验包括担任赛诺菲加拿大公司（Sanofi Canada Inc.）的首席财务官和联合临时首席执行官，该公司是全球梦百合领导者赛诺菲（Sanofi）的加拿大子公司，他还担任Intellivax Inc.的首席财务官，一家生物技术公司，以17.5亿美元出售给葛兰素史克；一家专业制药公司Tribute Pharmaceuticals的创始人；Gennum Corporation的首席财务官，一家专注于电视和医疗设备市场的上市半导体公司。这些公司的规模从初创公司到收入超过20亿美元的公司不等。在这些职位上，Bloch先生为私人和上市公司获得了大量资金，获得了首次公开募股的经验，并领导了许多收购和合伙交易。
Peter Bloch has served as the Chief Executive Officer of mbley Advisors Corp since January 2018, and served as the Chief Executive Officer of BresoTec from Augt, 2018 to September 2023 and the Chief Executive Officer and Chairman of Bionik Laboratories Corp. from 2012 to 2018. Mr. Bloch holds a Bachelor of Commerce Hons from the University of Cape Town, and participated in the Executive IT Management Program at the Massachetts Institute of Technology and the Negotiation for Executives at Harvard Biness School. - Peter Bloch自2013年4月起担任公司首席执行官，自2014年2月起担任董事会主席。从2012年4月到2013年4月，Bloch先生担任我们的首席财务官。Bloch先生是CA的注册会计师，有着建立公共和私人技术公司的记录，主要是在生命科学行业。Bloch从2008年1月到2009年2月担任Just Energy（一家公共电力和天然气公司）首席财务官。自2011年12月起，Bloch先生还担任Enerspar Corp.的董事。他过去25年的执行管理经验包括担任赛诺菲加拿大公司（Sanofi Canada Inc.）的首席财务官和联合临时首席执行官，该公司是全球梦百合领导者赛诺菲（Sanofi）的加拿大子公司，他还担任Intellivax Inc.的首席财务官，一家生物技术公司，以17.5亿美元出售给葛兰素史克；一家专业制药公司Tribute Pharmaceuticals的创始人；Gennum Corporation的首席财务官，一家专注于电视和医疗设备市场的上市半导体公司。这些公司的规模从初创公司到收入超过20亿美元的公司不等。在这些职位上，Bloch先生为私人和上市公司获得了大量资金，获得了首次公开募股的经验，并领导了许多收购和合伙交易。
- Peter Bloch has served as the Chief Executive Officer of mbley Advisors Corp since January 2018, and served as the Chief Executive Officer of BresoTec from Augt, 2018 to September 2023 and the Chief Executive Officer and Chairman of Bionik Laboratories Corp. from 2012 to 2018. Mr. Bloch holds a Bachelor of Commerce Hons from the University of Cape Town, and participated in the Executive IT Management Program at the Massachetts Institute of Technology and the Negotiation for Executives at Harvard Biness School.
- Iris Bincovich
-
Iris Bincovich，2015年10月至2017年12月担任Kamedis Ltd.（以色列特拉维夫）全球营销和销售副总裁，2014年1月至2015年9月担任Starlet Derma Ltd.（以色列凯撒利亚）业务发展副总裁，2012年1月至2014年1月担任Pollogen Ltd.（以色列特拉维夫）业务部门经理。Bincovich女士拥有以色列海法Technion – Israel Institute of Technology化学学士学位、海法大学公共关系、广告和演讲副学士学位以及洛杉矶谷学院国际营销和商业发展副学士学位。
Iris Bincovich served as the Vice President Global Marketing & Sales, of Kamedis Ltd. (Tel Aviv, Israel) from October 2015 to December 2017, the Vice President Biness Development of Starlet Derma Ltd. (Caesarea, Israel) from January, 2014 to September 2015), and the Biness Unit Manager of Pollogen Ltd. (Tel Aviv, Israel) from January 2012 to January 2014. Ms. Bincovich holds a B.Sc. in Chemistry from the Technion – Israel Institute of Technology, Haifa, Israel, an Associate's degree in public relations, advertising and speaking from Haifa University, and an Associate's degree in international marketing and biness development from Los Angeles Valley College. - Iris Bincovich，2015年10月至2017年12月担任Kamedis Ltd.（以色列特拉维夫）全球营销和销售副总裁，2014年1月至2015年9月担任Starlet Derma Ltd.（以色列凯撒利亚）业务发展副总裁，2012年1月至2014年1月担任Pollogen Ltd.（以色列特拉维夫）业务部门经理。Bincovich女士拥有以色列海法Technion – Israel Institute of Technology化学学士学位、海法大学公共关系、广告和演讲副学士学位以及洛杉矶谷学院国际营销和商业发展副学士学位。
- Iris Bincovich served as the Vice President Global Marketing & Sales, of Kamedis Ltd. (Tel Aviv, Israel) from October 2015 to December 2017, the Vice President Biness Development of Starlet Derma Ltd. (Caesarea, Israel) from January, 2014 to September 2015), and the Biness Unit Manager of Pollogen Ltd. (Tel Aviv, Israel) from January 2012 to January 2014. Ms. Bincovich holds a B.Sc. in Chemistry from the Technion – Israel Institute of Technology, Haifa, Israel, an Associate's degree in public relations, advertising and speaking from Haifa University, and an Associate's degree in international marketing and biness development from Los Angeles Valley College.
- Roni Kamhi
-
Roni Kamhi，自2021年5月26日起担任B.I. Sky首席执行官。在此之前，Kamhi先生曾于2015年至2019年担任Kamedis的CDO。Kamhi先生拥有与马里兰大学合作的蒙哥马利学院信息系统学士学位。Kamhi先生在全球零售、电子商务和技术领域拥有超过20年的经验，专注于数字、分析和数据。Roni已将电子商务初创公司从早期阶段的营收规模扩大到九位数。
Roni Kamhi has also served as the Chief Executive Officer of B.I. Sky since May 26, 2021. Prior to that, Mr. Kamhi served as CDO in Kamedis from 2015 to 2019. Mr. Kamhi holds a B.A. in information systems from Montgomery College in collaboration with the University of Maryland. Mr. Kamhi has over 20 years of experience in global retail, eCommerce and technology with a foc on digital, analytics and data. Roni has scaled eCommerce startups from an early stage to nine figures in revenue. - Roni Kamhi，自2021年5月26日起担任B.I. Sky首席执行官。在此之前，Kamhi先生曾于2015年至2019年担任Kamedis的CDO。Kamhi先生拥有与马里兰大学合作的蒙哥马利学院信息系统学士学位。Kamhi先生在全球零售、电子商务和技术领域拥有超过20年的经验，专注于数字、分析和数据。Roni已将电子商务初创公司从早期阶段的营收规模扩大到九位数。
- Roni Kamhi has also served as the Chief Executive Officer of B.I. Sky since May 26, 2021. Prior to that, Mr. Kamhi served as CDO in Kamedis from 2015 to 2019. Mr. Kamhi holds a B.A. in information systems from Montgomery College in collaboration with the University of Maryland. Mr. Kamhi has over 20 years of experience in global retail, eCommerce and technology with a foc on digital, analytics and data. Roni has scaled eCommerce startups from an early stage to nine figures in revenue.
- Eyal Flom
-
Eyal Flom，自2023年9月起担任Innocan Pharma Corporation审计委员会成员，自2020年9月起担任Innocan Pharma Corporation薪酬委员会成员。Flom先生自2020年9月至2022年5月担任NurExone Biologic Corporation NRX.V：TSXV的董事会成员。Flom先生自2021年起担任Revium Recovery Inc. RVRC：OTC的董事会成员。Flom先生自1995年4月起担任以色列制药协会法律顾问，并自1997年起作为独立律师在以色列执业。Flom先生拥有特拉维夫大学的法学硕士学位和德比大学（特拉维夫校区）的MBA学位。
Eyal Flom has served as a member of the board of directors of NurExone Biologic corporation NRX.V: TSXV since September 2020 until May 2022. Mr. Flom serves as a member of the board of directors of Revium Recovery Inc. RVRC: OTC since 2021. Mr. Flom has served as the Israeli Pharmaceutical Association legal counsel since April 1995, and has practiced as an independent lawyer in Israel since 1997. Mr. Flom holds an LLM from Tel Aviv University and an MBA from Derby University (Tel Aviv Camp). - Eyal Flom，自2023年9月起担任Innocan Pharma Corporation审计委员会成员，自2020年9月起担任Innocan Pharma Corporation薪酬委员会成员。Flom先生自2020年9月至2022年5月担任NurExone Biologic Corporation NRX.V：TSXV的董事会成员。Flom先生自2021年起担任Revium Recovery Inc. RVRC：OTC的董事会成员。Flom先生自1995年4月起担任以色列制药协会法律顾问，并自1997年起作为独立律师在以色列执业。Flom先生拥有特拉维夫大学的法学硕士学位和德比大学（特拉维夫校区）的MBA学位。
- Eyal Flom has served as a member of the board of directors of NurExone Biologic corporation NRX.V: TSXV since September 2020 until May 2022. Mr. Flom serves as a member of the board of directors of Revium Recovery Inc. RVRC: OTC since 2021. Mr. Flom has served as the Israeli Pharmaceutical Association legal counsel since April 1995, and has practiced as an independent lawyer in Israel since 1997. Mr. Flom holds an LLM from Tel Aviv University and an MBA from Derby University (Tel Aviv Camp).
- Ralph C.L Bossino
-
Ralph C.L Bossino创立了Tamar Technologies Ltd.，自2018年起担任首席执行官，自2018年起担任董事会成员。在此之前，Bossino先生担任Brains Bioceutical，Corp.的董事会成员。Bossino先生自2014年10月以来一直在直布罗陀担任独立大律师，在此之前，他曾在Hassans International Law Firm（Gibraltar）担任协理。Bossino先生拥有法学学士学位（伦敦国王学院）和BVC（伦敦法学院）。
Ralph C.L Bossino founded Tamar Technologies Ltd. where he has served as the Chief Executive Officer since 2018 and a member of the board of directors since 2018. Prior to that, Mr. Bossino served as a member of the board of directors of Brains Bioceutical, Corp. Mr. Bossino has practiced as an independent barrister at law in Gibraltar since October 2014 and prior thereto practiced as an Associate at Hassans International Law Firm (Gibraltar). Mr. Bossino holds a a LLB Hons (King's College London) and BVC (College of Law, London). - Ralph C.L Bossino创立了Tamar Technologies Ltd.，自2018年起担任首席执行官，自2018年起担任董事会成员。在此之前，Bossino先生担任Brains Bioceutical，Corp.的董事会成员。Bossino先生自2014年10月以来一直在直布罗陀担任独立大律师，在此之前，他曾在Hassans International Law Firm（Gibraltar）担任协理。Bossino先生拥有法学学士学位（伦敦国王学院）和BVC（伦敦法学院）。
- Ralph C.L Bossino founded Tamar Technologies Ltd. where he has served as the Chief Executive Officer since 2018 and a member of the board of directors since 2018. Prior to that, Mr. Bossino served as a member of the board of directors of Brains Bioceutical, Corp. Mr. Bossino has practiced as an independent barrister at law in Gibraltar since October 2014 and prior thereto practiced as an Associate at Hassans International Law Firm (Gibraltar). Mr. Bossino holds a a LLB Hons (King's College London) and BVC (College of Law, London).
- Joshua A. Lintern
-
Joshua A. Lintern，自2022年9月起在Marsh Canada Limited担任国家行业领导–房地产与开发，在此之前，于2019年11月至2022年9月担任西部地区房地产行业领导高级副总裁。在此之前，Lintern先生于2014年10月至2019年10月在Dream Unlimited担任风险与保险总监。Lintern先生拥有圭尔夫大学环境科学学士学位和多伦多大学认证风险管理称号。
Joshua A. Lintern has served as National Indtry Leader – Real Estate & Development at Marsh Canada Limited since September 2022 and prior to that as Senior Vice President, stern Region Real Estate Indtry Lead, from November 2019 to September 2022. Prior to that Mr. Lintern served Director – Risk & Insurance at Dream Unlimited from October 2014 to October 2019. Mr. Lintern holds a B.Sc. in Environmental Science from University of Guelph and a Certified Risk Management Designation from the University of Toronto. - Joshua A. Lintern，自2022年9月起在Marsh Canada Limited担任国家行业领导–房地产与开发，在此之前，于2019年11月至2022年9月担任西部地区房地产行业领导高级副总裁。在此之前，Lintern先生于2014年10月至2019年10月在Dream Unlimited担任风险与保险总监。Lintern先生拥有圭尔夫大学环境科学学士学位和多伦多大学认证风险管理称号。
- Joshua A. Lintern has served as National Indtry Leader – Real Estate & Development at Marsh Canada Limited since September 2022 and prior to that as Senior Vice President, stern Region Real Estate Indtry Lead, from November 2019 to September 2022. Prior to that Mr. Lintern served Director – Risk & Insurance at Dream Unlimited from October 2014 to October 2019. Mr. Lintern holds a B.Sc. in Environmental Science from University of Guelph and a Certified Risk Management Designation from the University of Toronto.
高管简历
中英对照 | 中文 | 英文- Iris Bincovich
Iris Bincovich，2015年10月至2017年12月担任Kamedis Ltd.（以色列特拉维夫）全球营销和销售副总裁，2014年1月至2015年9月担任Starlet Derma Ltd.（以色列凯撒利亚）业务发展副总裁，2012年1月至2014年1月担任Pollogen Ltd.（以色列特拉维夫）业务部门经理。Bincovich女士拥有以色列海法Technion – Israel Institute of Technology化学学士学位、海法大学公共关系、广告和演讲副学士学位以及洛杉矶谷学院国际营销和商业发展副学士学位。
Iris Bincovich served as the Vice President Global Marketing & Sales, of Kamedis Ltd. (Tel Aviv, Israel) from October 2015 to December 2017, the Vice President Biness Development of Starlet Derma Ltd. (Caesarea, Israel) from January, 2014 to September 2015), and the Biness Unit Manager of Pollogen Ltd. (Tel Aviv, Israel) from January 2012 to January 2014. Ms. Bincovich holds a B.Sc. in Chemistry from the Technion – Israel Institute of Technology, Haifa, Israel, an Associate's degree in public relations, advertising and speaking from Haifa University, and an Associate's degree in international marketing and biness development from Los Angeles Valley College.- Iris Bincovich，2015年10月至2017年12月担任Kamedis Ltd.（以色列特拉维夫）全球营销和销售副总裁，2014年1月至2015年9月担任Starlet Derma Ltd.（以色列凯撒利亚）业务发展副总裁，2012年1月至2014年1月担任Pollogen Ltd.（以色列特拉维夫）业务部门经理。Bincovich女士拥有以色列海法Technion – Israel Institute of Technology化学学士学位、海法大学公共关系、广告和演讲副学士学位以及洛杉矶谷学院国际营销和商业发展副学士学位。
- Iris Bincovich served as the Vice President Global Marketing & Sales, of Kamedis Ltd. (Tel Aviv, Israel) from October 2015 to December 2017, the Vice President Biness Development of Starlet Derma Ltd. (Caesarea, Israel) from January, 2014 to September 2015), and the Biness Unit Manager of Pollogen Ltd. (Tel Aviv, Israel) from January 2012 to January 2014. Ms. Bincovich holds a B.Sc. in Chemistry from the Technion – Israel Institute of Technology, Haifa, Israel, an Associate's degree in public relations, advertising and speaking from Haifa University, and an Associate's degree in international marketing and biness development from Los Angeles Valley College.
- Nelson Halpern
Nelson Halpern，自1991年以来也是KHM特许专业会计师的合伙人。Halpern先生于1985年获得注册会计师称号，是艾伯塔省特许专业会计师协会的成员。由于他对社区和专业的贡献，他于2013年获得了“FCPA”资深特许会计师称号。Halpern先生拥有卡尔加里大学经济学学士学位。
Nelson Halpern has also been a Partner of KHM Chartered Professional Accountants since 1991. Mr. Halpern received his CPA designation in 1985 and is a member of the Chartered Professional Accountants of Alberta, and he received an "FCPA" designation as a Fellow Chartered accountant in 2013 for his contribution to his community and the profession. Mr. Halpern holds a B.A. in Economics from University of Calgary.- Nelson Halpern，自1991年以来也是KHM特许专业会计师的合伙人。Halpern先生于1985年获得注册会计师称号，是艾伯塔省特许专业会计师协会的成员。由于他对社区和专业的贡献，他于2013年获得了“FCPA”资深特许会计师称号。Halpern先生拥有卡尔加里大学经济学学士学位。
- Nelson Halpern has also been a Partner of KHM Chartered Professional Accountants since 1991. Mr. Halpern received his CPA designation in 1985 and is a member of the Chartered Professional Accountants of Alberta, and he received an "FCPA" designation as a Fellow Chartered accountant in 2013 for his contribution to his community and the profession. Mr. Halpern holds a B.A. in Economics from University of Calgary.
- Roni Kamhi
Roni Kamhi，自2021年5月26日起担任B.I. Sky首席执行官。在此之前，Kamhi先生曾于2015年至2019年担任Kamedis的CDO。Kamhi先生拥有与马里兰大学合作的蒙哥马利学院信息系统学士学位。Kamhi先生在全球零售、电子商务和技术领域拥有超过20年的经验，专注于数字、分析和数据。Roni已将电子商务初创公司从早期阶段的营收规模扩大到九位数。
Roni Kamhi has also served as the Chief Executive Officer of B.I. Sky since May 26, 2021. Prior to that, Mr. Kamhi served as CDO in Kamedis from 2015 to 2019. Mr. Kamhi holds a B.A. in information systems from Montgomery College in collaboration with the University of Maryland. Mr. Kamhi has over 20 years of experience in global retail, eCommerce and technology with a foc on digital, analytics and data. Roni has scaled eCommerce startups from an early stage to nine figures in revenue.- Roni Kamhi，自2021年5月26日起担任B.I. Sky首席执行官。在此之前，Kamhi先生曾于2015年至2019年担任Kamedis的CDO。Kamhi先生拥有与马里兰大学合作的蒙哥马利学院信息系统学士学位。Kamhi先生在全球零售、电子商务和技术领域拥有超过20年的经验，专注于数字、分析和数据。Roni已将电子商务初创公司从早期阶段的营收规模扩大到九位数。
- Roni Kamhi has also served as the Chief Executive Officer of B.I. Sky since May 26, 2021. Prior to that, Mr. Kamhi served as CDO in Kamedis from 2015 to 2019. Mr. Kamhi holds a B.A. in information systems from Montgomery College in collaboration with the University of Maryland. Mr. Kamhi has over 20 years of experience in global retail, eCommerce and technology with a foc on digital, analytics and data. Roni has scaled eCommerce startups from an early stage to nine figures in revenue.
- Eyal Kalo
Eyal Kalo，2017年8月至2022年1月在贝克曼库尔特担任科学团队负责人兼eSense-Lab Limited首席技术官。Kalo博士拥有以色列雷霍沃特魏茨曼科学研究所分子生物学博士学位，以及以色列拉马特甘Bar Ilan大学生物学理学学士学位。
Eyal Kalo served as scientific team leader at Beckman Coulter and Chief Technology Officer of eSense Lab Limited from August 2017 to January 2022. Dr. Kalo holds a Ph.D in molecular biology from the izmann Institute of Science, Rehovot, Israel, as ll as a B.Sc. in Biology from Bar Ilan University, Ramat Gan, Israel.- Eyal Kalo，2017年8月至2022年1月在贝克曼库尔特担任科学团队负责人兼eSense-Lab Limited首席技术官。Kalo博士拥有以色列雷霍沃特魏茨曼科学研究所分子生物学博士学位，以及以色列拉马特甘Bar Ilan大学生物学理学学士学位。
- Eyal Kalo served as scientific team leader at Beckman Coulter and Chief Technology Officer of eSense Lab Limited from August 2017 to January 2022. Dr. Kalo holds a Ph.D in molecular biology from the izmann Institute of Science, Rehovot, Israel, as ll as a B.Sc. in Biology from Bar Ilan University, Ramat Gan, Israel.
- Eyal Flom
Eyal Flom，自2023年9月起担任Innocan Pharma Corporation审计委员会成员，自2020年9月起担任Innocan Pharma Corporation薪酬委员会成员。Flom先生自2020年9月至2022年5月担任NurExone Biologic Corporation NRX.V：TSXV的董事会成员。Flom先生自2021年起担任Revium Recovery Inc. RVRC：OTC的董事会成员。Flom先生自1995年4月起担任以色列制药协会法律顾问，并自1997年起作为独立律师在以色列执业。Flom先生拥有特拉维夫大学的法学硕士学位和德比大学（特拉维夫校区）的MBA学位。
Eyal Flom has served as a member of the board of directors of NurExone Biologic corporation NRX.V: TSXV since September 2020 until May 2022. Mr. Flom serves as a member of the board of directors of Revium Recovery Inc. RVRC: OTC since 2021. Mr. Flom has served as the Israeli Pharmaceutical Association legal counsel since April 1995, and has practiced as an independent lawyer in Israel since 1997. Mr. Flom holds an LLM from Tel Aviv University and an MBA from Derby University (Tel Aviv Camp).- Eyal Flom，自2023年9月起担任Innocan Pharma Corporation审计委员会成员，自2020年9月起担任Innocan Pharma Corporation薪酬委员会成员。Flom先生自2020年9月至2022年5月担任NurExone Biologic Corporation NRX.V：TSXV的董事会成员。Flom先生自2021年起担任Revium Recovery Inc. RVRC：OTC的董事会成员。Flom先生自1995年4月起担任以色列制药协会法律顾问，并自1997年起作为独立律师在以色列执业。Flom先生拥有特拉维夫大学的法学硕士学位和德比大学（特拉维夫校区）的MBA学位。
- Eyal Flom has served as a member of the board of directors of NurExone Biologic corporation NRX.V: TSXV since September 2020 until May 2022. Mr. Flom serves as a member of the board of directors of Revium Recovery Inc. RVRC: OTC since 2021. Mr. Flom has served as the Israeli Pharmaceutical Association legal counsel since April 1995, and has practiced as an independent lawyer in Israel since 1997. Mr. Flom holds an LLM from Tel Aviv University and an MBA from Derby University (Tel Aviv Camp).